MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
4.270
-0.070 (-1.61%)
Aug 10, 2026, 2:35 PM EDT - Market open
MiMedx Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 355.17 | 418.63 | 348.88 | 321.48 | 267.84 | 242.02 | |
Revenue Growth | -2.36% | 19.99% | 8.52% | 20.03% | 10.67% | -2.50% |
Cost of Revenue | 75.12 | 73.01 | 60.07 | 54.63 | 48.32 | 39.63 |
Gross Profit | 280.05 | 345.62 | 288.81 | 266.84 | 219.53 | 202.39 |
Selling, General & Admin | 255.08 | 266.19 | 225.09 | 211.12 | 208.67 | 194.85 |
Depreciation & Amortization Expenses | 0.83 | 0.44 | 0.77 | 0.76 | 0.7 | 0.82 |
Research & Development | 15.38 | 15.1 | 12.34 | 12.67 | 12.7 | 9.93 |
Other Operating Expenses | - | - | -8.25 | 5.18 | 12.18 | 3.84 |
Total Operating Expenses | 271.3 | 281.73 | 229.94 | 229.73 | 234.25 | 209.44 |
Operating Income | 8.75 | 63.89 | 58.87 | 37.12 | -14.73 | -7.05 |
Total Non-Operating Income (Expense) | 2.78 | 2.38 | -1.57 | -6.48 | -5.02 | -5 |
Pretax Income | 11.53 | 66.26 | 57.29 | 30.63 | -19.75 | -12.05 |
Provision for Income Taxes | -5.29 | -17.68 | -15.3 | 36.81 | -0.21 | -0.25 |
Net Income | 6.24 | 48.58 | 42.42 | 58.23 | -30.2 | -10.29 |
Earnings From Discontinued Operations | - | - | 0.42 | -9.21 | -10.24 | 2.02 |
Net Income to Common | 6.24 | 48.58 | 42.42 | 58.23 | -30.2 | -10.29 |
Net Income Growth | -80.61% | 14.52% | -27.15% | - | - | - |
Shares Outstanding (Basic) | 148 | 148 | 147 | 116 | 113 | 110 |
Shares Outstanding (Diluted) | 149 | 150 | 149 | 146 | 113 | 110 |
Shares Change | -0.08% | 0.45% | 2.11% | 29.27% | 2.32% | 1.94% |
EPS (Basic) | 0.04 | 0.33 | 0.29 | 0.40 | -0.33 | -0.17 |
EPS (Diluted) | 0.04 | 0.32 | 0.28 | 0.37 | -0.33 | -0.17 |
EPS Growth | -80.95% | 14.29% | -24.32% | - | - | - |
Free Cash Flow | 44.5 | 72.97 | 64.52 | 24.79 | -19.41 | -5.2 |
Free Cash Flow Growth | -22.11% | 13.11% | 160.27% | - | - | - |
Free Cash Flow Per Share | 0.30 | 0.49 | 0.43 | 0.17 | -0.17 | -0.05 |
Gross Margin | 78.85% | 82.56% | 82.78% | 83.01% | 81.96% | 83.63% |
Operating Margin | 2.46% | 15.26% | 16.87% | 11.55% | -5.50% | -2.91% |
Profit Margin | 1.76% | 11.60% | 12.16% | 18.11% | -11.27% | -4.25% |
FCF Margin | 12.53% | 17.43% | 18.49% | 7.71% | -7.25% | -2.15% |
EBITDA | 20.41 | 78.77 | 64.91 | 40.54 | -10.68 | -1.87 |
EBITDA Margin | 5.75% | 18.82% | 18.60% | 12.61% | -3.99% | -0.77% |
EBIT | 8.75 | 63.89 | 58.87 | 37.12 | -14.73 | -7.05 |
EBIT Margin | 2.46% | 15.26% | 16.87% | 11.55% | -5.50% | -2.91% |
Effective Tax Rate | -45.90% | -26.69% | -26.70% | 120.15% | 1.04% | 2.05% |